Clinical trial
Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder
NCT00181636 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- Not reported
- Completion date
- October 31, 2006
- Enrollment
- 25
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.